Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

viatris limited - ticagrelor - film-coated tablet - ticagrelor

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

viatris limited - ticagrelor - film-coated tablet - ticagrelor

Jordan - Tiếng Anh - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الدولية للدواء - pharma international company - ticagrelor 90 mg/1 tab - 90 mg/1 tab

Jordan - Tiếng Anh - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الرام للصناعات الدوائية - ram pharmaceutical industries co. ltd. - ticagrelor 90 mg/1 tab - 90 mg/1 tab

Canada - Tiếng Anh - Health Canada

astrazeneca canada inc - ticagrelor - tablet - 90mg - ticagrelor 90mg - platelet aggregation inhibitors

Malta - Tiếng Anh - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - film-coated tablet - ticagrelor 90 mg - antithrombotic agents

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ticagrelor, quantity: 90 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; iron oxide yellow; macrogol 400; purified talc; mannitol; magnesium stearate; titanium dioxide; hyprolose; hypromellose - blooms the chemist ticagrelor, in combination with aspirin, is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) in adult patients with acute coronary syndromes (unstable angina [ua], non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]) including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ticagrelor, quantity: 90 mg - tablet, film coated - excipient ingredients: hypromellose; hyprolose; calcium hydrogen phosphate dihydrate; titanium dioxide; macrogol 400; iron oxide yellow; magnesium stearate; purified talc; mannitol - arx-ticagrelor, in combination with aspirin, is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) in adult patients with acute coronary syndromes (unstable angina [ua], non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]) including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - ticagrelor, quantity: 90 mg - tablet, film coated - excipient ingredients: sodium stearylfumarate; sodium lauryl sulfate; calcium hydrogen phosphate dihydrate; iron oxide yellow; titanium dioxide; pregelatinised maize starch; mannitol; purified talc; glyceryl caprylate/caprate; polyvinyl alcohol; maize starch - ticagrelor sandoz, in combination with aspirin, is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) in adult patients with acute coronary syndromes (unstable angina [ua], non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]) including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - ticagrelor 60 mg - film-coated tablet - 60 mg - ticagrelor 60 mg - ticagrelor